236 related articles for article (PubMed ID: 18988126)
21. The epiphany of data warehousing technologies in the pharmaceutical industry.
Barrett JS; Koprowski SP
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
[TBL] [Abstract][Full Text] [Related]
22. Can open-source drug R&D repower pharmaceutical innovation?
Munos B
Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
[TBL] [Abstract][Full Text] [Related]
23. Outsourcing drug discovery to India and China: from surviving to thriving.
Subramaniam S; Dugar S
Drug Discov Today; 2012 Oct; 17(19-20):1055-8. PubMed ID: 22542471
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical R&D: the road to positive returns.
David E; Tramontin T; Zemmel R
Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
[No Abstract] [Full Text] [Related]
25. Drug discovery in jeopardy.
Cuatrecasas P
J Clin Invest; 2006 Nov; 116(11):2837-42. PubMed ID: 17080187
[TBL] [Abstract][Full Text] [Related]
26. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
Grabowski H
Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
[TBL] [Abstract][Full Text] [Related]
27. [Remedy or painkiller? Concentration trends in Dutch pharmaceutical industry].
De Jong HW
Gewina; 1999; 22(1):46-57. PubMed ID: 11625501
[TBL] [Abstract][Full Text] [Related]
28. Lessons from 60 years of pharmaceutical innovation.
Munos B
Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
[TBL] [Abstract][Full Text] [Related]
29. [Public health and chemical-pharmaceutical companies].
Ribeiro MA
Hist Cienc Saude Manguinhos; 2000 Nov-2001 Feb; 7(3):607-26. PubMed ID: 16683337
[TBL] [Abstract][Full Text] [Related]
30. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
31. Drug discovery in pharmaceutical industry: productivity challenges and trends.
Khanna I
Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
[TBL] [Abstract][Full Text] [Related]
32. Pharma industry in India.
Sundaram VM
Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
[TBL] [Abstract][Full Text] [Related]
33. Effective executive management in the pharmaceutical industry.
Tran H; Kleiner BH
J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
[TBL] [Abstract][Full Text] [Related]
34. [History and major achievements of the Institute for Drug Research].
Simay A
Acta Pharm Hung; 2001; 71(1):7-12. PubMed ID: 11769099
[TBL] [Abstract][Full Text] [Related]
35. [Exodus of the big pharmaceutical companies from Sweden].
Werkö L
Lakartidningen; 2003 Nov; 100(47):3890-1. PubMed ID: 14719246
[No Abstract] [Full Text] [Related]
36. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
37. Value networks identify innovation in 21st century pharmaceutical research.
Edwards PJ
Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
[TBL] [Abstract][Full Text] [Related]
38. Industrial R&D paradigm shift to vaccines.
Maggon K
Biotechnol J; 2009 Apr; 4(4):458-61. PubMed ID: 19370719
[No Abstract] [Full Text] [Related]
39. Drug discovery: are productivity metrics inhibiting motivation and creativity?
Ullman F; Boutellier R
Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910
[TBL] [Abstract][Full Text] [Related]
40. Torching the Haystack: modelling fast-fail strategies in drug development.
Lendrem DW; Lendrem BC
Drug Discov Today; 2013 Apr; 18(7-8):331-6. PubMed ID: 23246516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
